Clinical
Advice amendment on acid
The TGA’s scheduling committee have recommended a change to the safety advice for azelaic acid Australian regulators have recommended altering the advice given to patients when using azelaic acid. The …
‘Enormous’ opportunity to motivate
Pharmacist-led conversations about RSV expected to increase with profession included in new NIP program, but survey findings reveal a need for more awareness One third of older Australians eligible for …
Long-term antidepressant use called into question
Antidepressants should be regularly reviewed with shared decision-making about whether to continue or stop, say experts who compiled new summary of evidence Researchers from Adelaide University and The University of …
Off-label quetiapine linked to safety concerns
Commonly prescribed medication for insomnia symptoms affects next-day performance in people with OSA, controlled trial finds Low-dose quetiapine in people with obstructive sleep apnea (OSA) and insomnia reduced OSA severity …
Influenza in the young and the old
The seasonal virus hits hard for those at each end of life’s spectrum. We look at vaccination and care tips for some of those most vulnerable to severe disease KEY …
Frailty: why medicines reviews matter
People living with frailty may benefit from more frequent medication reviews than those without, a new framework says The framework to prevent and manage frailty in older Australians has been …
Women’s confidence in contraceptive prescribing explored
Australian patients were asked how they felt about pharmacist supply and resupply of contraceptives and what would change their views Pharmacists are well-positioned and trusted for contraceptive resupply, but female …
Proposed draft update to dementia guidelines
Dementia care has “shifted significantly” say experts as proposed update to dementia clinical practice guidelines opens for consultation The first major draft update to the national clinical guidelines for dementia …
A shortage no more
TGA announces a feared clonidine shortage is no longer on the cards A forecast shortage of Catapres (clonidine) 150 mcg tablets is no longer expected to occur, the Therapeutic Goods …
‘Early warning’ on added workload with prescribing
No sign of burnout among prescribing pharmacists in NZ, but a ‘notable proportion’ show evidence of ‘overextension’ A study of New Zealand’s registered prescribing pharmacists has revealed that none of …
Are you ready to vaccinate?
Regulator issues reminder on vaccination compliance requirements as winter season looms The inspectors from the Victorian Pharmacy Authority (VPA) have issued a timely reminder to pharmacists and pharmacy owners on …
Higher-THC products linked to psychiatric adverse events
Anxiety, psychotic disorder and paranoia lead adverse reactions for THC-predominant medicinal cannabis products, new analysis of TGA data finds Medicinal cannabis products that are Category 5, containing less than 2% …